We provide advanced technology platforms optimized for high-expression cell line development, enabling high-cell-density production of monoclonal antibodies, antibody fragments, proteins, peptides, and vaccine candidates. We are also equipped to develop complex molecules like Biosimilars addressing the molecular complexities of physicochemical and biological attributes.
We have following technology platforms for high expression with desired quality:
Our Technology Platforms support the process development and pre-clinical manufacturing of monoclonal antibodies, antibody fragments, proteins, peptides and ADCs on the different Technology Platforms:
We offer high order physiocochemical and biological characterization of proteins, antibodies and peptides.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.